Search

everythinglearnresearchcommunity

for

Search:↓

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Lupus can cause hair loss and nail changes, with treatments available for both.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

A 66-year-old woman's thick scalp and hair loss were confirmed as lipedematous alopecia, a rare condition possibly influenced by genetics, with no effective treatment known.

Hair transplant surgery may cause alopecia areata, a new possible complication.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Mnemonics help improve memory in dermatology by up to 50%.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Oral Minoxidil could be a safe and effective alternative treatment for various non-androgenic alopecias.

Long-COVID has diverse, long-term health impacts, especially in young people.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.